Lupin Announces Partnership with Phil, Inc. in Support of SOLOSEC® (secnidazole)
- Monday, February 1, 2021, 7:03
- Finance
- Add a comment
MUMBAI, India and BALTIMORE, Feb. 1, 2021 /PRNewswire/ — Lupin Pharmaceuticals Inc. (Lupin), global pharmaceutical company, announced today a partnership with Phil, Inc., which helps deliver cost-effective next-generation access solutions for patients who are prescribed Solosec®…